Director Ferrari Richard sale 8,000 shares of Pulmonx Corp [LUNG]

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Pulmonx Corp shares valued at $25,280 were sold by Ferrari Richard on Jun 12 ’25. At $3.16 per share, Ferrari Richard sold 8,000 shares. The insider’s holdings dropped to 87,024 shares worth approximately $0.27 million following the completion of this transaction.

Also, Ferrari Richard purchased 5,438 shares, netting a total of over 16,368 in proceeds.

Before that, RICH FERRARI had added 8,000 shares to its account. In a trade valued at $25,307, the Director bought Pulmonx Corp shares for $3.16 each.

As published in their initiating research note from D. Boral Capital on March 10, 2025, Pulmonx Corp [LUNG] has been a Buy and the price target has been revised to $17. Analysts at Citigroup downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in mid December. As of June 04, 2024, Lake Street has initiated its “Buy” rating for LUNG. Earlier on February 23, 2024, Wells Fargo downgraded its rating. Their new recommendation was “an Equal weight” for LUNG stock which previously was a “an Overweight”.

Analyzing LUNG Stock Performance

On last trading session,, Pulmonx Corp [NASDAQ: LUNG] rose 6.19% to $3.09. The stock’s lowest price that day was $2.79, but it reached a high of $3.305 in the same session. During the last five days, there has been a surge of approximately 16.60%. Over the course of the year, Pulmonx Corp shares have dropped approximately -60.18%.

Support And Resistance Levels for Pulmonx Corp (LUNG)

RSI (Relative Strength Index) is 56.40 on the 14-day chart, showing neutral technical sentiment.

Is Pulmonx Corp subject to short interest?

Stocks of Pulmonx Corp saw a sharp steep in short interest on 2025-06-13 dropping by -0.14 million shares to 1.42 million. Data from Yahoo Finance shows that the short interest on 2025-05-15 was 1.56 million shares. A decline of -9.82% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 3.78 of the overall float, the days-to-cover ratio (short ratio) decline to 3.78.

Which companies own the most shares of Pulmonx Corp (LUNG)?

In terms of Pulmonx Corp share price expectations, FactSet research, analysts set an average price target of 10 in the next 12 months, up nearly 243.64% from the previous closing price of $2.91. Analysts anticipate Pulmonx Corp stock to reach 20 by 2025, with the lowest price target being 6. In spite of this, 4 analysts ranked Pulmonx Corp stock as Buy at the end of 2025. On September 05, 2023, Craig Hallum assigned a price target of “a Buy” to the stock and initiated coverage with a $18.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.